0001179110-22-000696.txt : 20220201 0001179110-22-000696.hdr.sgml : 20220201 20220201212024 ACCESSION NUMBER: 0001179110-22-000696 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220201 DATE AS OF CHANGE: 20220201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Carmona Jose CENTRAL INDEX KEY: 0001693612 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 22581315 MAIL ADDRESS: STREET 1: C/O INNOCOLL HOLDINGS PLC STREET 2: 3803 WEST CHESTER PIKE CITY: NEWTOWN SQUARE STATE: PA ZIP: 19073 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2022-01-31 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001693612 Carmona Jose C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY ST., SUITE 300 CAMBRIDGE MA 02139 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 6.75 2022-01-31 4 A 0 143750 0 A 2032-01-30 Common Stock 143750 143750 D Restricted Stock Units 2022-01-31 4 A 0 34500 0 A Common Stock 34500 34500 D 25% of this option shall vest on January 31, 2023, then in 12 equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares underlying the restricted stock units vest in four equal annual installments beginning on January 31, 2023. /s/ Joanne M. Protano, Attorney-in-Fact 2022-02-01